What You Should Know About Ego Death

June 15, 2022 12:01:49

Everyone has experienced it at least once in their lives: you walk into a room with purpose only to realize you have no idea what you came for. You stare at the room, racking your brain for information, but all you draw is a blank. This state of temporary amnesia is the concept behind ego death. Also referred to as ego dissolution, this term has been used in mystic and psychedelic communities for decades to describe a state of temporary autobiographical amnesia.

Think of that moment of brain fog stretching over time, leaving you floating in a cloud of nothingness as you swim in a state of temporary amnesia. You have no idea who you are, where you come from or why you even exist. This is ego death, a psychological condition where a fully conscious individual temporarily “forgets” everything about themselves. Those who have experienced it say it felt like all the weight of the biographical selves had been lifted off their bodies, leaving them feeling “light and pleasant.”

However, it isn’t always a pleasant experience for everyone. Some individuals who experience ego death the first time they use psychedelics may think they will remain in that state forever, and they panic and are overcome with horror. Others may believe that they have died and passed into a new world, making the term ego death even more appropriate.

But the truth is that while drug-induced ego death can be extremely profound, it is always temporary, and it fades away. Some people may go through ego death for a few minutes while others can last hours depending on the type of psychedelic and dose. Longer-lasting drugs such as LSD and psilocybin tend to produce longer-lasting ego death while short-duration psychedelics can result in a short but intense state of ego death.

This phenomenon usually occurs due to unusual activity in an area of the brain called the hippocampus. It is located in the medial temporal lobe and is responsible for storing and retrieving memories. Experts believe high doses of psychedelics can disrupt the flow of information from the hippocampus to the executive areas responsible for working memory.

A scanning study conducted by researchers at Imperial College found that psilocybin causes ego dissolution by decreasing functional connectivity between the medial temporal lobe and high-level cortical regions. As ego death starts to wane, your autobiographical memories start to flood back into consciousness. This cycle of death and rebirth is integral to psychedelic spirituality and healing.

A separate study found that ayahuasca drinkers who experienced ego death saw a reduction in stress and depression as well as an increase in mindfulness and satisfaction with life.

There are still huge gaps that exist in our understanding of psychedelics and how they work, and the clinical development programs being undertaken by companies such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) will hopefully shed more light on why these substances impact mental health in such diverse ways from traditional treatments.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.